Translating Guidelines and Clinical Trial Data to and ... - Amazon S3

More documents

Recommendations

Info

ALL Relapse <strong>and</strong> Its Affect onPatient SurvivalRelapsed ALL is the 7th MostCommon Childhood MalignancyCases/10 6 children/y year353025201510530.927.69.78.4 8.3Relapse ALL6.65.64.5 3.90AML = acute myeloid leukemia.Adapted from: Gaynon PS, et al. Cancer. 1998;82(7):1387-1395.
Algorithm for Treatment of BMRelapse ALL in ChildrenBM RelapseCombined withExtramedullary LocalizationIsolatedTreat asIsolatedBM Relapse+ +SR (BCP-ALL Relapsing>6 Months fromTreatmentDiscontinuation)HR (BCP-ALL Relapsing
Page 1 and 2: Translating Guidelinesand Clinical
Page 3 and 4: Distribution of the Common Chromoso
Page 6 and 7: MRD on Day 29 of Induction Predicts
Page 8 and 9: Case 1:13-cv-10020-MLW Document 1 F
Page 11 and 12: CCG-Modified Standard BFMInduction(
Page 13 and 14: EFS During 5 Years ofFollow-Up in A
Page 15 and 16: Maintenance• Daily mercaptopurine
Page 17 and 18: Risk Stratification: Pediatric, T-C
Page 19 and 20: “Targeted Therapy”Ph+ ALL in Ch
Page 21: Adolescents and Young AdultsInducti
Page 25 and 26: Pre-BMT MRD PredictsPost-BMT Relaps
Page 27 and 28: Clofarabine, Etoposide, and CPM in
Page 29 and 30: Toll-Like Receptors• TLR are patt
Page 31 and 32: Translating Guidelines and Clinical
Page 33 and 34: 17. How often do you intend to use

Translating Guidelines and Clinical Trial Data to and ... - Amazon S3

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?